Monovalent cation transport during the cell cycle (review). 1982

J Boonstra, and C L Mummery, and E J van Zoelen, and P T van der Saag, and S W de Laat

This paper reviews the properties and regulation of cation transport during the cell cycle. Extensive modulations occur in both electro-diffusional and non-electro-diffusional cation transport, most prominently during mitosis and G1 phase. These modulations can be related to compositional, structural and dynamic membrane properties. The implications of modulated cation transport for progression through the cell cycle are discussed.

UI MeSH Term Description Entries
D007473 Ion Channels Gated, ion-selective glycoproteins that traverse membranes. The stimulus for ION CHANNEL GATING can be due to a variety of stimuli such as LIGANDS, a TRANSMEMBRANE POTENTIAL DIFFERENCE, mechanical deformation or through INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS. Membrane Channels,Ion Channel,Ionic Channel,Ionic Channels,Membrane Channel,Channel, Ion,Channel, Ionic,Channel, Membrane,Channels, Ion,Channels, Ionic,Channels, Membrane
D008564 Membrane Potentials The voltage differences across a membrane. For cellular membranes they are computed by subtracting the voltage measured outside the membrane from the voltage measured inside the membrane. They result from differences of inside versus outside concentration of potassium, sodium, chloride, and other ions across cells' or ORGANELLES membranes. For excitable cells, the resting membrane potentials range between -30 and -100 millivolts. Physical, chemical, or electrical stimuli can make a membrane potential more negative (hyperpolarization), or less negative (depolarization). Resting Potentials,Transmembrane Potentials,Delta Psi,Resting Membrane Potential,Transmembrane Electrical Potential Difference,Transmembrane Potential Difference,Difference, Transmembrane Potential,Differences, Transmembrane Potential,Membrane Potential,Membrane Potential, Resting,Membrane Potentials, Resting,Potential Difference, Transmembrane,Potential Differences, Transmembrane,Potential, Membrane,Potential, Resting,Potential, Transmembrane,Potentials, Membrane,Potentials, Resting,Potentials, Transmembrane,Resting Membrane Potentials,Resting Potential,Transmembrane Potential,Transmembrane Potential Differences
D008938 Mitosis A type of CELL NUCLEUS division by means of which the two daughter nuclei normally receive identical complements of the number of CHROMOSOMES of the somatic cells of the species. M Phase, Mitotic,Mitotic M Phase,M Phases, Mitotic,Mitoses,Mitotic M Phases,Phase, Mitotic M,Phases, Mitotic M
D002453 Cell Cycle The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE. Cell Division Cycle,Cell Cycles,Cell Division Cycles,Cycle, Cell,Cycle, Cell Division,Cycles, Cell,Cycles, Cell Division,Division Cycle, Cell,Division Cycles, Cell
D002463 Cell Membrane Permeability A quality of cell membranes which permits the passage of solvents and solutes into and out of cells. Permeability, Cell Membrane
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001693 Biological Transport, Active The movement of materials across cell membranes and epithelial layers against an electrochemical gradient, requiring the expenditure of metabolic energy. Active Transport,Uphill Transport,Active Biological Transport,Biologic Transport, Active,Transport, Active Biological,Active Biologic Transport,Transport, Active,Transport, Active Biologic,Transport, Uphill

Related Publications

J Boonstra, and C L Mummery, and E J van Zoelen, and P T van der Saag, and S W de Laat
December 1972, Journal of cellular physiology,
J Boonstra, and C L Mummery, and E J van Zoelen, and P T van der Saag, and S W de Laat
April 1984, Circulation research,
J Boonstra, and C L Mummery, and E J van Zoelen, and P T van der Saag, and S W de Laat
August 1978, The Journal of clinical investigation,
J Boonstra, and C L Mummery, and E J van Zoelen, and P T van der Saag, and S W de Laat
September 1996, Biochemistry,
J Boonstra, and C L Mummery, and E J van Zoelen, and P T van der Saag, and S W de Laat
January 1978, Progress in clinical and biological research,
J Boonstra, and C L Mummery, and E J van Zoelen, and P T van der Saag, and S W de Laat
March 1995, Clinical science (London, England : 1979),
J Boonstra, and C L Mummery, and E J van Zoelen, and P T van der Saag, and S W de Laat
November 2019, Journal of materials chemistry. B,
J Boonstra, and C L Mummery, and E J van Zoelen, and P T van der Saag, and S W de Laat
January 1973, Physiological chemistry and physics,
J Boonstra, and C L Mummery, and E J van Zoelen, and P T van der Saag, and S W de Laat
March 1991, The Journal of physiology,
J Boonstra, and C L Mummery, and E J van Zoelen, and P T van der Saag, and S W de Laat
January 1986, Developmental pharmacology and therapeutics,
Copied contents to your clipboard!